Banu Atalar, Professor of Radiation Oncology at Anadolu Medical Center Hospital, shared Piet Ost’s, Radiation Oncologist at Iridium Network Antwerppost on X, adding:
“As someone who has never truly been a believer in pelvic RT, I find these results incredibly encouraging and practice-changing.
Very impressive data presented at ESTRO2026.”
Quoting Piet Ost’s post:
“PEACE 2 phase III: Adding pelvic RT to prostate RT + 3y ADT in very high-risk localized prostate cancer did NOT improve bPFS, MFS, CSS or OS. Borderline cPFS signal (HR 0.81, p=0.09). No added AEs.
Pierre Blanchard, ESTRO2026. Vedang Murthy what now?”
Other articles featuring Banu Atalar and Piet Ost on OncoDaily.
